Journal of Pain and Symptom Management
Volume 39, Issue 1 , Pages 33-43 , January 2010

End-of-Life Decision Making for Cancer Patients in Different Clinical Settings and the Impact of the LCP

  • Agnes van der Heide, MD, PhD

      Affiliations

    • Department of Public Health, Erasmus Medical Center, Rotterdam, The Netherlands
    • Corresponding Author InformationAddress correspondence to: Agnes van der Heide, MD, PhD, Department of Public Health, Erasmus Medical Center, P.O. Box 2040, 3000 CA Rotterdam, The Netherlands.
    • ,
  • Laetitia Veerbeek, MSc

      Affiliations

    • Department of Public Health, Erasmus Medical Center, Rotterdam, The Netherlands
    • ,
  • Siebe Swart, MD

      Affiliations

    • Department of Public Health, Erasmus Medical Center, Rotterdam, The Netherlands
    • ,
  • Carin van der Rijt, MD, PhD

      Affiliations

    • Department of Internal Oncology, Erasmus MC-Daniel den Hoed Cancer Center, Rotterdam, The Netherlands
    • ,
  • Paul J. van der Maas, MD, PhD

      Affiliations

    • Department of Public Health, Erasmus Medical Center, Rotterdam, The Netherlands
    • ,
  • Lia van Zuylen, MD, PhD

      Affiliations

    • Department of Internal Oncology, Erasmus Medical Center, Rotterdam, The Netherlands

,Accepted 17 June 2009.

References 

  1. World Health Organization. WHO definition of palliative care. Available from http://www.who.int/cancer/palliative/definition/en/Accessed May 17, 2009
  2. Plonk WM, Arnold RM. Terminal care: the last weeks of life. J Palliat Med. 2005;8:1042–1054
  3. Lynn J, Teno JM, Phillips RS, et al. Perceptions by family members of the dying experience of older and seriously ill patients. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. Ann Intern Med. 1997;126:97–106
  4. Teno JM, Clarridge BR, Casey V, et al. Family perspectives on end-of-life care at the last place of care. JAMA. 2004;291:88–93
  5. Toscani F, Di Giulio P, Brunelli C, Miccinesi G, Laquintana D. How people die in hospital general wards: a descriptive study. J Pain Symptom Manage. 2005;30:33–40
  6. DeSilva DL, Dillon JE, Teno JM. The quality of care in the last month of life among Rhode Island nursing home residents. Med Health RI. 2001;84:195–198
  7. Hall P, Schroder C, Weaver L. The last 48 hours of life in long-term care: a focused chart audit. J Am Geriatr Soc. 2002;50:501–506
  8. Reynolds K, Henderson M, Schulman A, Hanson LC. Needs of the dying in nursing homes. J Palliat Med. 2002;5:895–901
  9. van der Heide A, Deliens L, Faisst K, et al. EURELD Consortium End-of-life decision-making in six European countries: descriptive study. Lancet. 2003;362:345–350
  10. van der Heide A, Onwuteaka-Philipsen BD, Rurup ML, et al. End-of-life practices in the Netherlands under the Euthanasia Act. N Engl J Med. 2007;356:1957–1965
  11. Ellershaw J, Foster A, Murphy D. Developing an integrated care pathway for the dying patient. Eur J Palliat Care. 1997;4:203–207
  12. Ellershaw JE, Murphy D. The Liverpool Care Pathway (LCP) influencing the UK national agenda on care of the dying. Int J Palliat Nurs. 2005;11:132–134
  13. Veerbeek L, van Zuylen L, Swart SJ, et al. The effect of the Liverpool Care Pathway for the Dying: a multi centre study. Palliat Med. 2008;22:145–151
  14. The Marie Curie Palliative Care Institute. Liverpool Care Pathway for the Dying Patient. Available from http://www.mcpcil.org.uk/liverpool-care-pathway/Accessed May 17, 2009
  15. Sneeuw KC, Aaronson NK, Sprangers MA, et al. Comparison of patient and proxy EORTC QLQ-C30 ratings in assessing the quality of life of cancer patients. J Clin Epidemiol. 1998;51:617–631
  16. Lichter I, Hunt E. The last 48 hours of life. J Palliat Care. 1990;6:7–15
  17. Klinkenberg M, Willems DL, van der Wal G, Deeg DJ. Symptom burden in the last week of life. J Pain Symptom Manage. 2004;27:5–13
  18. Ellershaw J, Smith C, Overill S, Walker SE, Aldridge J. Care of the dying: setting standards for symptom control in the last 48 hours of life. J Pain Symptom Manage. 2001;21:12–17
  19. Chochinov HM, Hack T, Hassard T, et al. Dignity in the terminally ill: a cross-sectional, cohort study. Lancet. 2002;360:2026–2030
  20. Coyle N, Adelhardt J, Foley KM, Portenoy RK. Character of terminal illness in the advanced cancer patient: pain and other symptoms during the last four weeks of life. J Pain Symptom Manage. 1990;5:83–93
  21. Klinkenberg M, Smit JH, Deeg DJ, et al. Proxy reporting in after-death interviews: the use of proxy respondents in retrospective assessment of chronic diseases and symptom burden in the terminal phase of life. Palliat Med. 2003;17:191–201
  22. McPherson CJ, Addington-Hall JM. Evaluating palliative care: bereaved family members' evaluations of patients' pain, anxiety and depression. J Pain Symptom Manage. 2004;28:104–114
  23. Lloyd-Williams M. Screening for depression in palliative care patients: a review. Eur J Cancer Care. 2001;10:31–35
  24. Ferris FD, Von Gunten CF, Emanuel LL. Ensuring competency in end-of-life care: controlling symptoms. BMC Palliat Care. 2002;1:5
  25. Sood A, Barton DL, Loprinzi CL. Use of methylphenidate in patients with cancer. Am J Hosp Palliat Care. 2006;23:35–40
  26. Rozans M, Dreisbach A, Lertora JJ, Kahn MJ. Palliative uses of methylphenidate in patients with cancer: a review. J Clin Oncol. 2002;20:335–339
  27. Veerbeek L, van Zuylen L, Swart SJ, van der Maas PJ, van der Heide A. The last 3 days of life in three different care settings in the Netherlands. Support Care Cancer. 2007;15:1117–1123
  28. de Vogel-Voogt E, van der Heide A, van Leeuwen AF, et al. Patient evaluation of end-of-life care. Palliat Med. 2007;21:243–248
  29. Rietjens J, van Delden J, Onwuteaka-Philipsen B, et al. Continuous deep sedation for patients nearing death in the Netherlands: descriptive study. BMJ. 2008;336:810–813
  30. van Zuylen C, Oostendorp FM, Van Beusekom BR, et al. [Increasing drug use in nursing homes], [Dutch] Ned Tijdschr Geneeskd. 1988;132:1692–1695
  31. Bosshard G, Nilstun T, Bilsen J, et al. European End-of-Life Consortium Forgoing treatment at the end of life in 6 European countries. Arch Intern Med. 2005;16:401–407
  32. Groenewoud JH, van der Heide A, Kester JG, et al. A nationwide study of decisions to forego life-prolonging treatment in Dutch medical practice. Arch Intern Med. 2000;160:357–363

 Funding for the study was provided through an internal grant from Erasmus Medical Center.

PII: S0885-3924(09)00788-X

doi: 10.1016/j.jpainsymman.2009.05.018

Journal of Pain and Symptom Management
Volume 39, Issue 1 , Pages 33-43 , January 2010

Article Tools